Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Advanced Course on Perioperative Strategies in Localized Malignancies: State of the Art and Future Directions in Lung Cancer 2024: Hong Kong SAR

Session 5 - Management of Stage III non-oncogene driven lung cancer

Should we give I/O to all Stage III patients after concurrent chemoradiation?

Date

20 Apr 2024

Session

Session 5 - Management of Stage III non-oncogene driven lung cancer

Topics

Surgical Oncology

Tumour Site

Thoracic Malignancies

Presenters

Rina Hui, HK SAR CN

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.